4.10
0.24 (6.22%)
0.24 (6.22%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Briacell Therapeutics Corporation (QB) | BCTXF | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.24 | 6.22% | 4.10 | 16:13:35 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.09 | 4.09 | 4.11 | 4.10 | 3.86 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.66 | 4.12 | 0.46 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6 | 1,070 | $ 4.1008 | $ 4,388 | 315 | 0.022455 - 20.36 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:51:19 | 500 | $ 4.10 | USD |
Briacell Therapeutics (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.17M | 771.96k | 480.28k | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 316.00 | $ - | 0.00% | - | - |
Briacell Therapeutics (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCTXF Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.7705 | 4.11 | 3.6906 | 3.72 | 666 | 0.3295 | 8.74% |
| 1 Month | 4.10 | 4.25 | 3.6906 | 3.99 | 1,267 | 0.00 | 0.0% |
| 3 Months | 4.64 | 4.84 | 3.25 | 4.11 | 760 | -0.54 | -11.64% |
| 6 Months | 6.75 | 7.31 | 3.25 | 5.05 | 895 | -2.65 | -39.26% |
| 1 Year | 0.0328 | 20.36 | 0.022455 | 0.2330872 | 30,401 | 4.07 | 12,400.0% |
| 3 Years | 0.1013 | 20.36 | 0.022455 | 0.1186991 | 30,909 | 4.00 | 3,947.38% |
| 5 Years | 0.1669 | 20.36 | 0.022455 | 0.1242433 | 27,295 | 3.93 | 2,356.56% |
Briacell Therapeutics (QB) Description
| BriaCell is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs INCMGA00012 and epacadostat (listed in ClinicalTrials.gov as NCT03328026). BriaCell currently has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates. Additionally, BriaCell is developing Bria-OTS, an off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing. Bria-OTS, expected to cover over 99 percent of the patient population, is designed to produce a potent and selective immune response against the cancer of each patient while eliminating the time, expense and complex manufacturing logistics associated with other personalized immunotherapies. |
